Obesity / Weight Maintenance · Currently recruiting
Tirzepatide-to-Brenipatide Switch (GZMX)
For adults who have maintained weight loss on once-weekly tirzepatide (10 mg): a study of whether switching to once-monthly brenipatide maintains that weight loss, and whether the switch is safe.
Study details
Condition: Obesity / Weight Maintenance
Status: Recruiting
Protocol: J2S-MC-GZMX
Site: EndoTrials Clinical Research Center, La Mesa, California
Full eligibility criteria are set by the study protocol. Our research team will review them with you, explain what participation involves, including visits, procedures and compensation where applicable, and answer your questions before you decide. Participation is voluntary, and you can withdraw at any time.
EndoTrials is the clinical research center of Diabetes & Endocrine Specialists, led by Darius A. Schneider, MD, PhD.